| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 465.30B | 462.08B | 462.87B | 451.41B | 408.20B |
| Gross Profit | 174.97B | 169.42B | 165.29B | 166.00B | 149.80B |
| EBITDA | 52.41B | 58.22B | 54.68B | 65.14B | 60.34B |
| Net Income | 23.70B | 13.35B | 29.64B | 38.18B | 37.27B |
Balance Sheet | |||||
| Total Assets | 617.57B | 591.28B | 666.84B | 594.21B | 580.66B |
| Cash, Cash Equivalents and Short-Term Investments | 108.95B | 99.82B | 101.59B | 103.89B | 172.50B |
| Total Debt | 16.65B | 19.96B | 17.93B | 17.67B | 27.90B |
| Total Liabilities | 137.83B | 141.16B | 155.02B | 136.26B | 163.79B |
| Stockholders Equity | 478.35B | 448.83B | 510.59B | 456.84B | 415.71B |
Cash Flow | |||||
| Free Cash Flow | 31.65B | 32.35B | 20.92B | -35.57B | 21.49B |
| Operating Cash Flow | 45.78B | 55.28B | 43.84B | -14.84B | 36.02B |
| Investing Cash Flow | -7.91B | 8.11B | -15.90B | -21.56B | 43.71B |
| Financing Cash Flow | -37.77B | -63.14B | -37.26B | -35.29B | -44.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥250.08B | 19.80 | ― | 2.18% | 8.08% | -27.93% | |
73 Outperform | ¥2.38T | 17.78 | 15.67% | 1.94% | 8.60% | 10.04% | |
71 Outperform | ¥176.14B | 11.00 | ― | 3.40% | 6.49% | -11.12% | |
70 Neutral | ¥121.07B | 17.64 | ― | 4.78% | 4.15% | -73.12% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥504.14B | 20.93 | 3.68% | 2.35% | 0.70% | 95.26% | |
56 Neutral | ¥26.82B | 21.29 | ― | 3.56% | -1.19% | 181.64% |